Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry

@article{Wohlfarth2014MetabolismOS,
  title={Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry},
  author={A. Wohlfarth and Adarsh S Gandhi and Shaokun Pang and M. Zhu and K. Scheidweiler and M. Huestis},
  journal={Analytical and Bioanalytical Chemistry},
  year={2014},
  volume={406},
  pages={1763-1780}
}
  • A. Wohlfarth, Adarsh S Gandhi, +3 authors M. Huestis
  • Published 2014
  • Chemistry, Medicine
  • Analytical and Bioanalytical Chemistry
    • AbstractBackgroundPB-22 (1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid) and 5F-PB-22 (1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid) are new synthetic cannabinoids with a quinoline substructure and the first marketed substances with an ester bond linkage. No human metabolism data are currently available, making it difficult to document PB-22 and 5F-PB-22 intake from urine analysis, and complicating assessment of the drugs’ pharmacodynamic and toxicological… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    89 Citations
    Highly Influencial Citations
    5
    Background Citations
    25
    Methods Citations
    8
    Results Citations
    5
    89 Citations
    Citation Type

    Citation Type

    Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry.
    • 46
    Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA
    • 76
    Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    • 19
    In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.
    • 18
    • PDF
    Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans
    • 11
    • PDF
    Human urinary metabolite pattern of a new synthetic cannabimimetic, methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate
    • 8
    High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes.
    • 57
    • PDF
    High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.
    • 39
    Human Hepatocyte Metabolism of Novel Synthetic Cannabinoids MN-18 and Its 5-Fluoro Analog 5F-MN-18.
    • 5
    • PDF
    Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    • 33

    References

    SHOWING 1-10 OF 32 REFERENCES
    First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry.
    • 77
    • PDF
    First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry
    • 68
    Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in
    • 109
    Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A-834735, cathinone derivative 4-methoxy-α-PVP, and phenethylamine derivative 4-methylbuphedrine from illegal products
    • 30
    URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products.
    • 130
    • Highly Influential
    Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
    • 118
    • Highly Influential
    • PDF
    Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products
    • 137
    • Highly Influential
    Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures.
    • 131
    • PDF
    Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS
    • Qiang Zhang, P. Ma, R. Cole, G. Wang
    • Chemistry, Medicine
    • Analytical and bioanalytical chemistry
    • 2006
    • 67
    Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine.
    • 89
    • Highly Influential